Our CRO has developed a solid experience in Observational Studies, Pathology Registries and Phase Studies since 2007, strengthening its knowledge with the Hospital Establishments and the Scientific Companies.

MISSION

The mission of CD Pharma is to guide the Client’s projects with its structure, in order to achieve the pre-established objectives, with quality and punctuality.

vision-mission-concept.jpg

ORGANIZATION

A team of managers with solid experience in conducting Clinical Studies is at the service of all the components that interact and ensure the smooth running

Writing an article is somewhat different than composing a standard essay . You should consider searching for one more essay writer if you aren’t confident in your writing abilities. I advise that you begin by doing some research on the subject you are currently writing about. Have a look at some of the very best college essays and find out how they come across. I think you’ll be impressed with the results.

of the project.

ADDED VALUE

It is represented by an experienced and close-knit team of resources who have worked together for years on the most important therapeutic areas and with most of the hospital facilities.

THE SUCCESS OF A CLINICAL STUDY DEPENDS ON DIFFERENT FACTORS

WE GUIDE YOU AND SUPPORT YOU IN ALL OPERATIONAL PHASES

  • Optimal selection of the hospital or medical center
  • Assured quality in all phases of the clinical study
  • Targeted choice for laboratory services
  • Specialized logistical services
  • Budget optimization

REPRESENTING OURSELVES THROUGH

  • Unified vision of the clinical trial system
  • Centralization of clinical trial information: documents and data
  • Project oriented organization
  • Supporting processes with advanced technology

.

SERVICES

WE ARE ABLE TO SUPPORT ALL THE PHASES OF A CLINICAL STUDY

Always in compliance with the ICH / GCP / ISO 14 155 Guidelines, applicable regulations and SOPs of reference.
Our competences concern the management of Interventional and Observational Clinical Studies and the coordination of activities for Pathology Registries.

CLINICAL OPERATION

  • Support for revision of protocols
  • Selection of the centers to be involved
  • Trial Start Up
  • Investigator Meeting Organization
  • Monitoring activity
  • Essential Documents Management
  • Final clinical report

e-CRF AND DATA MANAGEMENT

  • Paper and electronic CRF planning and design
  • Simple and complex electronic controls of the e-CRF
  • Programs for data validation checks with SAS
  • Data validation plan
  • Data Coding according to standard dictionaries

.

STATISTICS

  • Writing of the statistical section of the protocol
  • Preparation of the randomization lists
  • Statistical analysis plan
  • Programming and SAS
  • Statistical analysis and preparation of tables, graphs, lists and appendices
  • Statistical Report
  • Meta-analysis

 

Experiences

THERAPEUTIC AREAS

The therapeutic areas in which we operate are:

  • ANESTHESIA
  • ALLERGOLOGY
  • CARDIOLOGY
  • DERMATOLOGY
  • HEMOPHILIA
  • GASTROENTEROLOGY
  • GYNECOLOGY
  • INFECTIOUS DISEASES
  • NEUROLOGY
  • ONCOHEMATOLOGY
  • ONCOLOGY
  • PNEUMOLOGY
  • RHEUMATOLOGY
  • UROLOGY

TARGET

Our main targets are:

  • PHARMACEUTICAL COMPANIES
  • MEDICAL DEVICE COMPANIES
  • HOSPITAL INSTITUTIONS
  • STUDY GROUPS
  • SCIENTIFIC COMMUNITIES

 


  • Alfasigma

    Almirall

    Alvimedica

    Amgen

    BioMarin

    Bristol-Myers Squibb

    CSL Behring

    Glaxo SmithKline

    Lofarma

    Mediolanum Farmaceutici

    Mylan

    Novartis

    Pfizer

    Roche

    Shionogi

    Sobi

    Stallergenes

    Zambon

  • ADOI

    GISEA

    GRIMAD

    LORHEN

    SIMG

    SIMIT

    SIR

 

 

Quality

There are many things which you can do, if you require help with your paper afterward. You may pay someone to write you your paper. You can read these papers’ examples over to see how this functions. But you could also use your own creativity and your research and expertise to turn a typical paper.

COMPANY QUALITY POLICY

CD Pharma Group srl is involved in the world of clinical research of drugs and medical devices.
Our mission is to reach our clients with their goals, with innovation and quality, in an ethical and professional way, always offering a high standard of competence and professionalism, with services that are always in line with the regulatory provisions, but also with those company values that CD Pharma has been promoting since its establishment. We want to offer projects characterized by a strong scientific value, that is both technological and methodological, providing services that quickly respond to the ever-changing needs that may develop.

We have implemented an organizational system based on the UNI EN ISO 9001:2015
certificato_TUV_miniatura.gif

international model using the analysis of the business context and the analysis of risks and opportunities as primary tools to achieve the lasting development of the Company in the interests of the expectations of the Clientele and all the Company’s interested parties (Stakeholders).
The Company measures its processes and results through process indicators that allow it to define improvement targets on a periodic basis.
In CD Pharma we live according to a set of shared values, enclosed in our Code of Ethics, which guide the conduct of business processes and activities, as well as the Company’s relations with personnel and third parties:

Client centrality: maximum customer satisfaction is our main goal. Everything we do is aimed at responding to the needs of the client, of which we want to be an indispensable partner. We promote the care of direct communication to know and better understand their requirements and needs. We are committed to providing products and services built on the specific needs of the client, ensuring quality and excellence. The goal is to conquer and maintain the esteem and respect of our Clients also with regard to the professionalism we offer in our relationships.
Innovation and creativity: We are always attentive to developments in the sector in which we operate to offer cutting-edge services. We accept and encourage change, challenging the state of things. We encourage people to be resourceful, take risks and learn from their mistakes. We are always looking for new ideas. Strengthened by a consolidated experience, a continuous deepening of new technologies and a creative component, we support Clients in the realization of innovative and successful projects through the partnership with qualified suppliers.
Efficiency: we offer an integrated service with the use of Internet technologies for the development of our clients’ business. We set ourselves ambitious goals and aim to surpass them, considering ourselves mutually responsible for the results.
Human Resources: We prioritize the growth and professional development of talented people. We recognize and reward the results. We give autonomy to our staff so that they can contribute by expressing their full potential. We respect the staff and we believe in open and honest communication. Our values influence the way we work and interact with our colleagues, as well as the way we follow our clients and engage with all our stakeholders.

This policy is disseminated and communicated to all the personnel of CD Pharma through a specific document and published on the company website. The same is revisited on the occasion of each management review.

AUTOCERTIFIED AT AIFA IN ACCORDANCE WITH THE MINIMUM REQUIREMENTS PROVIDED BY THE DM 15/11/2011

STANDARD OPERATING PROCEDURES

The CD Pharma CRO has an internal system of Standard Operating Procedures that regulates all the processes concerning a Clinical Study: from the start-up, to the data collection, up to the production of an end-of-study report.
The development and use of Standard Operating Procedures is at the basis of the effectiveness of the ISO 9001 certified Quality Management System and guarantees, to each individual belonging to the organization, the necessary information to correctly perform his / her job, thus assuring the adherence of processes to technical requirements and compliance with regulatory requirements.

VALIDATION OF eCRF SOFTWARE

CD Pharma uses web-based software belonging to the category of Electronic Data Capture that allows, without any kind of installation, the following features:

  • Planning of the eCRF and the database
  • Data collection and integrated reporting
  • Emissions of clinical queries up to the management of any changes in the data under the guidance of the clinical data management processes
  • Electronic signature of the PI on the eCRF of each individual patient

The software for the implementation of eCRF have requirements defined within:

ICH Topic E6 – Guidelines for Good Clinical Practice – (CPMP / ICH / 135/95)
Guidance for Industry – Computerized System used in Clinical Investigations
21 CFR part 11 – Electronic Records and Electronic Signature

The System that is validated according to these principles guarantees:

  • Access control
  • Audit Trail
  • “ALCOA” data (attributable, legible, complete, original and accurate)
  • Standard operating procedures for using the computerized system
  • • Documentation that identifies which software and hardware are used by computerized systems that create, modify, archive, retrieve or transmit clinical data

Validation evidence is part of the study documentation and is always available in case of an inspection.

CONSULTING

Thanks to the experience gained in recent years on topics related to therapeutic areas characterized by a strong social impact and by the relationship with Stakeholders who are particularly attentive to these aspects, we have focused on the implementation of “Partnership Program”” projects, according to a methodological approach that allows the achievement of objectives through an in-depth process on the following topics:

  • Analysis of the scenario
  • Timely definition of the needs of the territory
  • Provision of services
  • Continuous fine tuning of activities
  • Constant analysis of results

iStock-531933576-e1537351628697.jpg


CD Pharma is focused on the design of projects whose objectives are to produce:

  • Expert Paper
  • Consensus Paper
  • PDTAs
  • Guidelines
  • HTA Report
  • Registration dossiers

Privacy Policy

Information document Article 13 EU Reg. 2016/679 – GDPR – Information on the processing of personal data collected from the interested party

In compliance with the provisions of EU Reg. 2016/679 European Regulation for the protection of personal data) we provide the necessary information regarding the processing of personal data provided. The information must not be considered valid for other websites that may be consulted through links on the domain owner’s internet sites, which are not to be considered in any way responsible for third party websites. This is information that is provided pursuant to art. 13 of EU Reg. 2016/679 (European Regulation for the protection of personal data) and is also inspired by the provisions of Directive 2002/58 / EC, as updated by Directive 2009/136/CE, regarding Cookies and envisaged by the Provision of the Authority for the protection of personal data of 08.05.2014 on cookies.
Personal data that can be processed: «personal data»: any information concerning an identified or identifiable natural person («interested party»); an individual is identified as identifiable, either directly or indirectly, with particular reference to an identifier such as a name, an identification number, location data, an online identifier or one or more characteristic elements of his physical, physiological, genetic, psychological, economic, cultural or social identity; (C26, C27, C30).

Navigation data
The computer systems and software procedures used to operate this site acquire, during their normal operation, some personal data whose transmission is implicit in the use of Internet communication protocols. This category of data includes IP addresses or domain names of computers and terminals used by users, addresses in URI / URL notation (Uniform Resource Identifier / Locator) of the requested resources, the time of the request, the method used in the submit the request to the server, the file size obtained in response, the numerical code indicating the status of the response given by the server (success, error, etc.) and other parameters related to the operating system and the user’s computer environment.

Data communicated by the interested party
The optional, explicit and voluntary sending of messages to the contact addresses, as well as the compilation and forwarding of the forms on the website of the Owner, involves the acquisition of contact data of the sender, necessary to respond, as well as all data personal data included in communications.

Specific information
Informative specifiche potrebbero essere presentate nelle pagine del sito, in relazione a particolari servizi o trattamenti dei dati forniti.

Cookies and other technologies
For more information on cookies and other technologies used, see the cookies policy in the footer of this website.

1 TITLE HOLDER OF THE DATA USE, pursuant to art. 4 and 24 of the EU Reg. 2016/679 is CD Pharma Group Srl, Piazza Ernesto De Angeli 7, 20146 – Milan – Italy, in the figure of the legal representative, Telephone: 02.890510768, contact by e-mail info@cdpharma.it

2 DATA PROTECTION MANAGER (RPD / DPO – Data Protection Officer), pursuant to art. 37 – 39 of EU Reg. 2016/679, contact by e-mail dpo@cdpharma.it

3 PURPOSE AND LEGAL BASIS OF DATA USE
Personal data will be processed for the following purposes:
A) -navigation on the website: the data necessary for the use of web services are also processed in order to obtain statistical information on the use of services (most visited pages, number of visitors per hour or day, geographical areas of origin, etc.) and to check the correct functioning of the services offered;
LEGAL BASIS: Data will be processed in compliance with the conditions of lawfulness pursuant to art. 6 EU Reg. 2016/679:
– on the basis of the execution of a contract or implementation of pre-contractual measures taken at the request of the party concerned; – on the basis of the processing necessary for the pursuit of the legitimate interest of the data controller or third parties, provided that the interests or the fundamental rights and freedoms of the data subject who request the protection of personal data do not prevail and also taking into account reasonable expectations harbored by the data subject at the time and in the context of the collection of personal data, when the data subject can reasonably be expected to be processed for that purpose (recital 47);

4 ADDRESSEES OR CATEGORIES OF DATA ADDRESSEES
Personal data will be communicated to recipients, who will process data as managers (Article 28 of EU Reg. 2016/679) and / or as natural persons acting under the authority of the Data Controller and the Data Processor (art. 29 of EU Reg. 2016/679), for the purposes listed above in point 3 and to third parties. Specifically, the data will be communicated to:
-Expressly identified and authorized service providers; – subjects that provide services for the management of the information system and communication networks (including e-mail); – studies or companies in the context of assistance and consultancy relationships; – competent authorities for compliance with legal obligations and / or provisions of public bodies, upon request; – in case of administrative and accounting purposes, the data may eventually be sent to commercial information companies for the assessment of solvency and payment habits and / or subjects for purposes of debt collection. The subjects belonging to the aforesaid categories perform the function of Data Processing Manager, or operate in complete autonomy as separate Data Controllers. The list of data processors is constantly updated and available by writing to dpo@cdpharma.it

5 DATA TRANSFER TO A THIRD-PARTY COUNTRY AND / OR AN INTERNATIONAL ORGANIZATION AND GUARANTEES
Personal data will not be transferred to non-EU countries.

6 PERIOD OF CONSERVATION OF DATA OR CRITERIA FOR DETERMINING THE PERIOD
The processing will be carried out in an automated and manual way, with methods and tools aimed at guaranteeing maximum security and confidentiality, by subjects specifically appointed to do so. In compliance with the provisions of art. 5 paragraph 1 letter e) of Reg. UE 2016/679 the personal data collected will be stored in a form that allows identification of data subjects for a period of time not exceeding the achievement of the purposes for which the personal data are processed. In particular, Personal Data will be processed for a period of time equal to the minimum necessary, as indicated in Recital 39 of the Rules, i.e. until the termination of existing contractual and pre-contractual relationships, without prejudice to a further retention period that may be imposed by law as also provided by Recital 65 of the Rules. The timing is determined on the basis of criteria of which the interested party can have information by writing to dpo@cdpharma.it

7 RIGHTS OF THE INTERESTED PARTIES
The interested parties have the right to obtain, in the cases provided for, access to personal data and the correction or deletion of the same or the limitation of processing that concerns them or to oppose the treatment (Articles 15 and following of EU Regulation 2016 / 679). You can assert your rights by contacting the DPO, by sending an e-mail to the address dpo@cdpharma.it or by writing to the office of the owner indicated above. You have the right to lodge a complaint with the Control Authority.

8 CONFERENCE
You are free to provide personal data in dedicated areas. Failure to provide personal data will make it impossible to use the services offered by the data controller.

9 CHANGES TO THE PRIVACY POLICY
The owner reserves the right to change, update, add or remove portions of this privacy statement at their discretion and at any time. You are required to periodically check for any changes. In order to facilitate this verification, the information will contain the indication of the update date of the information.
Update date 25.05.18

Contacts

Thus you are wondering, what’s writing essays? The easiest answer to that question is that writing essays is doing precisely the identical thing that writing a newspaper would do – get feedback on it and write something down. Its portion comes from the very first step: by writing around you, you have to begin. For many students who don’t have much experience in writing, this may seem daunting. Remember that you don’t have to worry about getting your article published, but you’ll be asked to write about your own thoughts and experiences.